CLAREMONT, Calif., Dec. 19, 2006 (PRIME NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT) announced that it has started to develop its potential markets in Shouguang in Shandong Province and Inner Mongolia.
On December, 2006, Mr. Wei Li, CEO of Kiwa, had a formal meeting with Mr. Leyi Wang, who is Board Chairman of Shouguang Century Sanyuan Modern Agriculture Co., Ltd. in Shouguang, Shandong province. With 300,000 temperature-keeping sheds for vegetables, Shouguang is one of the largest vegetable shed-planting bases in China. Mr. Wang, expert of the field of shed-planting, has decided to add three of Kiwa's relevant products into his plan of fertilizing in the year of 2007; he also discussed with Mr. Li in details on the application test plans of a number of other Kiwa's products. Up to now, testing of Kiwa's sample products has been carried out in Shouguang.
On December 5, 2006, Ms. Juhua Wang, Chief Operating Officer of Kiwa, Prof. Qi Wang, Vice Director of R&D Center and the Manager of Marketing Center visited Yakeshi, Inner Mongolia, and met with Mr. Pengju Liu, Chairman of Qiansen Agriculture Group (Qiansen). By negotiation, Qiansen agreed to promote Kiwa's fertilizer products such as CHAOFEIBAO, Organic Fertilizer and Bacillus spp. Preparation in its 10,000 mu plantation. (Note: The mu is a traditional Chinese unit of land measure equal to one-fifteenth of a hectare.) Ms. Wang also inspected the whole Hulunbeir market. Statistics show that Hulunbeir now possesses a plantation area of over 20 million mu, which accounts for 50% of the whole Inner Mongolia plantation area. Agriculture in such place characterizes in intensification and industrialization. Kiwa is now in the early stage of exploring the market in Hulunbeir, and management expects to develop the market by engaging the direct-sales pattern.
Mr. Wei Li, Chairman and CEO of Kiwa, stated, "We are excited to see the huge potential of these two markets. Management believes that it is a golden opportunity for the Company to explore the market, promote its products and generate value for the shareholders."
About Kiwa Bio-Tech Products Group Corporation
The Company develops, manufactures, and distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development.
For more information about the Company, please visit the Company's website at http://www.kiwabiotech.com.
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.